PRRT2 and breast cancer: Furthermore, activation of the ERBB family of receptor tyrosine kinases, which are frequently over-stimulated in different types of cancer, such as breast cancer, results in the release of diacylglycerol, which is the endogenous activator of PKC [5], [6], [7].